Adrian Grzybowski, PhD, is an accomplished scientist with expertise in immunomodulation and antibody engineering. Currently serving as Chief Science Officer and Co-founder at AnuBio, Adrian focuses on closed-loop lab-AI drug discovery aimed at reprogramming immune responses. Previously, Adrian was the Tech Lead for antibody engineering at Triplebar, where responsibilities included supervising immunomodulatory antibody discovery and overseeing advanced cellular screening techniques. As Group Leader in Antibody Engineering at Alamar Biosciences, Adrian managed numerous antibody discovery campaigns and significantly increased biophysical characterization throughput. With a robust background including postdoctoral research at the Joint BioEnergy Institute and various scientific roles at the University of Chicago, Adrian holds a PhD in Cellular and Molecular Biology, and has contributed to multiple innovative methodologies, securing significant venture capital financing.
This person is not in the org chart
This person is not in any teams
This person is not in any offices